221 related articles for article (PubMed ID: 11322792)
1. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.
Suguna K; Surolia A; Surolia N
Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792
[TBL] [Abstract][Full Text] [Related]
2. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors.
Kapoor M; Dar MJ; Surolia A; Surolia N
Biochem Biophys Res Commun; 2001 Dec; 289(4):832-7. PubMed ID: 11735121
[TBL] [Abstract][Full Text] [Related]
3. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.
Surolia N; Surolia A
Nat Med; 2001 Feb; 7(2):167-73. PubMed ID: 11175846
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the variation in triclosan affinity to enoyl reductases.
Pidugu LS; Kapoor M; Surolia N; Surolia A; Suguna K
J Mol Biol; 2004 Oct; 343(1):147-55. PubMed ID: 15381426
[TBL] [Abstract][Full Text] [Related]
5. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase.
Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A
IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.
Kapoor M; Gopalakrishnapai J; Surolia N; Surolia A
Biochem J; 2004 Aug; 381(Pt 3):735-41. PubMed ID: 15139852
[TBL] [Abstract][Full Text] [Related]
7. Structural basis and mechanism of enoyl reductase inhibition by triclosan.
Stewart MJ; Parikh S; Xiao G; Tonge PJ; Kisker C
J Mol Biol; 1999 Jul; 290(4):859-65. PubMed ID: 10398587
[TBL] [Abstract][Full Text] [Related]
8. A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase.
Levy CW; Baldock C; Wallace AJ; Sedelnikova S; Viner RC; Clough JM; Stuitje AR; Slabas AR; Rice DW; Rafferty JB
J Mol Biol; 2001 May; 309(1):171-80. PubMed ID: 11491286
[TBL] [Abstract][Full Text] [Related]
9. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.
Frecer V; Megnassan E; Miertus S
Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192
[TBL] [Abstract][Full Text] [Related]
10. Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy.
Surolia N; RamachandraRao SP; Surolia A
Bioessays; 2002 Feb; 24(2):192-6. PubMed ID: 11835284
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A
J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517
[TBL] [Abstract][Full Text] [Related]
12. Exploring the interaction energies for the binding of hydroxydiphenyl ethers to enoyl-acyl carrier protein reductases.
Muralidharan J; Suguna K; Surolia A; Surolia N
J Biomol Struct Dyn; 2003 Feb; 20(4):589-94. PubMed ID: 12529157
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
Shah P; Siddiqi MI
SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
[TBL] [Abstract][Full Text] [Related]
14. X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition.
Maity K; Bhargav SP; Sankaran B; Surolia N; Surolia A; Suguna K
IUBMB Life; 2010 Jun; 62(6):467-76. PubMed ID: 20503440
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.
Freundlich JS; Anderson JW; Sarantakis D; Shieh HM; Yu M; Valderramos JC; Lucumi E; Kuo M; Jacobs WR; Fidock DA; Schiehser GA; Jacobus DP; Sacchettini JC
Bioorg Med Chem Lett; 2005 Dec; 15(23):5247-52. PubMed ID: 16198563
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for triclosan activity involves a flipping loop in the active site.
Qiu X; Janson CA; Court RI; Smyth MG; Payne DJ; Abdel-Meguid SS
Protein Sci; 1999 Nov; 8(11):2529-32. PubMed ID: 10595560
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives.
Freundlich JS; Yu M; Lucumi E; Kuo M; Tsai HC; Valderramos JC; Karagyozov L; Jacobs WR; Schiehser GA; Fidock DA; Jacobus DP; Sacchettini JC
Bioorg Med Chem Lett; 2006 Apr; 16(8):2163-9. PubMed ID: 16466916
[TBL] [Abstract][Full Text] [Related]
18. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene.
Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA
Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and structural analysis of the increased affinity of enoyl-ACP (acyl-carrier protein) reductase for triclosan in the presence of NAD+.
Kapoor M; Mukhi PL; Surolia N; Suguna K; Surolia A
Biochem J; 2004 Aug; 381(Pt 3):725-33. PubMed ID: 15125687
[TBL] [Abstract][Full Text] [Related]
20. Crystallographic analysis of triclosan bound to enoyl reductase.
Roujeinikova A; Levy CW; Rowsell S; Sedelnikova S; Baker PJ; Minshull CA; Mistry A; Colls JG; Camble R; Stuitje AR; Slabas AR; Rafferty JB; Pauptit RA; Viner R; Rice DW
J Mol Biol; 1999 Nov; 294(2):527-35. PubMed ID: 10610777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]